These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 21222121)
1. Roles and mechanisms of microRNAs in pancreatic cancer. Zhang L; Jamaluddin MS; Weakley SM; Yao Q; Chen C World J Surg; 2011 Aug; 35(8):1725-31. PubMed ID: 21222121 [TBL] [Abstract][Full Text] [Related]
2. Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives. Rahnama N; Jahangir M; Alesaeid S; Kahrizi MS; Adili A; Mohammed RN; Aslaminabad R; Akbari M; Özgönül AM Pathol Res Pract; 2022 Aug; 236():153982. PubMed ID: 35779293 [TBL] [Abstract][Full Text] [Related]
3. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy. Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997 [TBL] [Abstract][Full Text] [Related]
4. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer. Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis. Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096 [TBL] [Abstract][Full Text] [Related]
6. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma. Chen B; Zhang Q; Wang X; Wang Y; Cui J; Zhuang H; Tang J Aging (Albany NY); 2020 Feb; 12(4):3647-3661. PubMed ID: 32090981 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer. Kanno S; Nosho K; Ishigami K; Yamamoto I; Koide H; Kurihara H; Mitsuhashi K; Shitani M; Motoya M; Sasaki S; Tanuma T; Maguchi H; Hasegawa T; Kimura Y; Takemasa I; Shinomura Y; Nakase H Carcinogenesis; 2017 Apr; 38(4):425-431. PubMed ID: 28186267 [TBL] [Abstract][Full Text] [Related]
8. Critical role of miRNAs in pancreatic cancer. Liu B; Zhang X; Mao AW Front Biosci (Landmark Ed); 2015 Jun; 20(7):1017-28. PubMed ID: 25961540 [TBL] [Abstract][Full Text] [Related]
9. Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer. Chen D; Wu X; Xia M; Wu F; Ding J; Jiao Y; Zhan Q; An F Oncol Rep; 2017 Oct; 38(4):2182-2188. PubMed ID: 28849236 [TBL] [Abstract][Full Text] [Related]
10. The Role of MicroRNAs in the Chemoresistance of Breast Cancer. Wang J; Yang M; Li Y; Han B Drug Dev Res; 2015 Nov; 76(7):368-74. PubMed ID: 26310899 [TBL] [Abstract][Full Text] [Related]
11. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266 [TBL] [Abstract][Full Text] [Related]
12. miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. Qiu Z; Wang X; Shi Y; Da M Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):997-1007. PubMed ID: 31518383 [TBL] [Abstract][Full Text] [Related]
13. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1. Wang J; Wang B; Ren H; Chen W Biochem Biophys Res Commun; 2019 Jan; 509(1):241-248. PubMed ID: 30591220 [TBL] [Abstract][Full Text] [Related]
14. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Long M; Zhan M; Xu S; Yang R; Chen W; Zhang S; Shi Y; He Q; Mohan M; Liu Q; Wang J Mol Cancer; 2017 Oct; 16(1):167. PubMed ID: 29078789 [TBL] [Abstract][Full Text] [Related]
15. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling. Li J; Wu H; Li W; Yin L; Guo S; Xu X; Ouyang Y; Zhao Z; Liu S; Tian Y; Tian Z; Ju J; Ni B; Wang H Oncogene; 2016 Oct; 35(42):5501-5514. PubMed ID: 27065335 [TBL] [Abstract][Full Text] [Related]
16. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer. Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053 [TBL] [Abstract][Full Text] [Related]
17. LncRNA XIST enhanced TGF-β2 expression by targeting miR-141-3p to promote pancreatic cancer cells invasion. Sun J; Zhang Y Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213574 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression. Yan J; Jia Y; Chen H; Chen W; Zhou X J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171 [TBL] [Abstract][Full Text] [Related]
19. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer. Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409 [TBL] [Abstract][Full Text] [Related]
20. LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis. Wei G; Lu T; Shen J; Wang J Biochem Biophys Res Commun; 2020 Aug; 528(4):644-649. PubMed ID: 32513531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]